Characterization of the cellular immune function of patients with chronic mucocutaneous candidiasis

Clinical and Experimental Immunology

Volumn 123, Issue 2, 2001, Pages 247-253

  De Moraes Vasconcelos, D ^a   Orii, N M ^a   Romano, C C ^a   Iqueoka, R Y ^a   Da S Duarte, A J ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Activation induced cell death; Apoptosis; Cellular immunity; Chronic mucocutaneous candidiasis; Cytokines

Indexed keywords

CANDIDA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MYELOPEROXIDASE; PHYTOHEMAGGLUTININ; POKEWEED MITOGEN; TUBERCULIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; CANDIDA; CELL STRAIN K 562; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; MUCOCUTANEOUS CANDIDIASIS; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CANDIDIASIS, CHRONIC MUCOCUTANEOUS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MALE; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0035114291     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01430.x     Document Type: Article

References (31)

1. Disorders of the T-cell system
2. Invasive fungal infections in patients with chronic mucocutaneous candidiasis
3. Case report: Familial chronic mucocutaneous candidiasis complicated by deep Candida infection
4. Mucocutaneous candidiasis. Anergy and a plasma inhibitor of cellular immunity: Reversal with amphotericin B
5. Immunodeficiencies in chronic mucocutaneous candidiasis
6. Immune abnormalities associated with chronic mucocutaneous candidiasis
7. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharide antigens present in the serum of patients with chronic mucocutaneous candidiasis
8. Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro
9. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans
10. Chronic mucocutaneous candidiasis. I. Altered antigen-stimulated IL-2, IL-4, IL-6 and interferon-gamma (IFN-γ) production
11. Production of T-helper cell subsets and cytokines by lymphocytes from patients with chronic mucocutaneous candidiasis
12. Changes in human natural killer activity early and late after renal transplantation using conventional immunosuppression
13. Annexin V for flow cytometry detection of phosphatidylserine expression on B cells undergoing apoptosis
14. Chronic mucocutaneous candidiasis
15. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans
16. Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: Responses to IL-2, IFN-γ and IL-12
17. Natural killer cell activity in experimental paracoccidioidomycosis of the Syrian hamster
18. Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro
19. IL-12 and IL-18 synergistically induce the fungicidal activity of murine exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells
20. Antigen-specific immunosuppression in paracoccidioidomycosis
21. Immunosuppression in Paracoccidioidomycosis: T cell hyporesponsiveness to two Paracoccidioides brasiliensis glycoproteins that elicit strong humoral immune response
22. Cellular immunity in recurrent vulvovaginal candidiasis
23. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood
24. CD95-induced apoptosis contributes to loss of primed/memory but not resting/naive T cells in children infected with human immunodeficiency virus type 1
25. Fas ligand mediates activation-induced cell death in human lymphocytes
26. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation
27. Signaling events in T lymphocytes leading to cellular activation or programmed cell death
28. Regulation of CD95 (Fas) ligand expression by TcR-mediated signaling events
29. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance